Observation of Effect on Low Molecular Heparin Calcium Combined with Sodium Ozagrel in the Treatment for Acute Attack of Pulmonary Heart Disease

Objective To investigate the effect of low molecular heparin calcium combined with sodium ozagrel in the treatment for acute attack of pulmonary heart disease. Methods 102 cases with acute attack of pulmonary heart disease in our hospital from January 2008 to January 2009 were randomly divided into the A group,B group and C group,A group received the treatment of low molecular heparin calcium,B group received the treatment of sodium ozagrel,and C group received the treatment of low molecular heparin calcium combined with sodium ozagrel. Results PO2 and PCO2 of three group after treatment was superior to that before treatment,and there was significant difference among them respectively (P 0.05). PO2 in the A group and B group was lower than that in C group,and there was significant difference in them respectively (P 0.05). There was no significant difference with PO2 in A group and B group (P 0.05). PCO2 in the A group and in B group was higher than that in C group,and there was significant difference in them respectively (P 0.05). There was no significant difference with PCO2 in A group and B group (P 0.05). The total effective rate was 76.47% in A group,73.53% in B group and 97.06% in C group,and the total effective rate in A group and in B group was lower than that in C group,and there was significant difference in them respectively (P 0.05). There was no significant difference in A group and B group (P 0.05). Conclusion The effect of low molecular heparin calcium combined with sodium ozagrel in the treatment for acute attack of pulmonary heart disease is obvious,which is worthy of clinical application.